Industry Updates Category Banner

Industry Updates

This broad category includes articles concerning health insurance costs, carrier and health plan news, changing benefits technology, and surveys by the Kaiser Family Foundation and others on employee benefits.

92% Of SMBs Say Policymakers Aren’t Doing Enough On Health Benefits

Owners of small and mid-sized businesses wish policymakers would take more notice of their health benefits problems. About 92% of the owners who participated in a recent online survey agreed with the statement that “government leaders aren’t doing enough” to address their health benefits problems. Even more, 93%, agreed that policymakers should come up with ...

Read More

Employers Brace For A 9% Jump In Health Care Costs, Largest In Over A Decade

Big U.S. employers expect median health care costs to rise 9% in 2026, according to new survey data from the Business Group on Health. That’s up from an 8% employer increase forecast for 2025, and it appears to be the biggest annual increase forecast that the employers have provided since 2010, when the Business Group on ...

Read More

Covered California Health Insurance Will Cost More In 2026. Here’s What’s Behind The Double-Digit Increase

Millions of consumers will feel the pinch when rates already expected to rise will jump even further. Federal subsidies, set to expire at year’s end, are partly to blame.

Read More

New CMS Data Suggest Future ACA Market Turmoil As Feds Crack Down On Fraud

The Centers for Medicare & Medicaid Services (CMS) this week released new data fueling a narrative of rampant broker fraud on the Affordable Care Act (ACA) exchanges. Plans received data finding 23% of enrollees did not have a claim in 2019. That number jumped sharply to 35% last year. Before the pandemic, the data were ...

Read More

CBO: Reconciliation Package Could Lead To $500B In Medicare Cuts Over Next Decade

A new analysis from the Congressional Budget Office (CBO) warns that Republicans’ massive tax bill could lead to hundreds of billions in cuts to Medicare over the next 10 years. CBO analysts, in a letter (PDF) to key Democratic senators Friday, dug into the potential impact the One Big Beautiful Bill Act could have on federal programs ...

Read More

How Health Systems Are Bracing For Tariffs

As the Trump administration moves forward with sweeping tariffs aimed at increasing U.S. manufacturing, health systems are ramping up efforts to protect patients from potential effects. At Renton, Wash.-based Providence, COO Darryl Elmouchi, MD, said the health system has implemented a supply chain risk management program to help prepare for challenges with respect to tariffs. ...

Read More

Armed With Pricing Data, Employers May Confront New Legal Obligations When Selecting Health Plans

National pricing data show the cost of healthcare services varies greatly by payer, geography, setting and facility, presenting new fiduciary considerations for employers. Since 2022, health plans have been required to release machine-readable files disclosing negotiated rates of healthcare services with providers. Hospitals are also required to release the costs of shoppable services. Data analytics ...

Read More

Big Pharma Has a New Vision for Selling Drugs. It’s Going to the Mattresses

Amid pressure from the White House, U.S. drug companies are experimenting with direct-to-consumer sales models that cut out the middlemen.

Read More

GoodRx and Novo Nordisk: A Strategic Alliance Reshaping Diabetes Drug Pricing and Market Access

The partnership between GoodRx and Novo Nordisk represents a seismic shift in the diabetes drug sector, redefining pricing power and market access for GLP-1 receptor agonists (GLP-1RAs). By slashing the cash price of Ozempic and Wegovy to $499 per month for self-paying patients, the collaboration not only addresses affordability gaps but also positions both firms ...

Read More

Trump Orders Stockpiling Of Advanced Drug Ingredients

President Trump on Wednesday ordered his health officials to secure a six-month supply of advanced pharmaceutical ingredients for drugs the administration determines are critical for national health and security. Why it matters: The move continues efforts started during the Biden administration to reshore the medical supply chain and reduce the reliance on overseas manufacturers, especially China. The government ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square